serine has been researched along with Giant Axonal Neuropathy in 1 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Giant Axonal Neuropathy: Rare autosomal recessive disorder of INTERMEDIATE FILAMENT PROTEINS. The disease is caused by mutations in the gene that codes gigaxonin protein. The mutations result in disorganization of axonal NEUROFILAMENT PROTEINS, formation of the characteristic giant axons, and progressive neuropathy. The clinical features of the disease include early-onset progressive peripheral motor and sensory neuropathies often associated with central nervous system involvement (INTELLECTUAL DISABILITY, seizures, DYSMETRIA, and CONGENITAL NYSTAGMUS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PH | 1 |
| Hu, J | 1 |
| Wu, J | 1 |
| Huynh, DT | 1 |
| Smith, TJ | 1 |
| Pan, S | 1 |
| Bisnett, BJ | 1 |
| Smith, AB | 1 |
| Lu, A | 1 |
| Condon, BM | 1 |
| Chi, JT | 1 |
| Boyce, M | 1 |
1 other study available for serine and Giant Axonal Neuropathy
| Article | Year |
|---|---|
Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatment
Topics: Acetylglucosamine; Antigens, Neoplasm; Binding Sites; Cell Line; Cytoskeletal Proteins; Epigenesis, | 2020 |